Outset Medical cash flow, quarter by quarter

In Q3 2026, Outset Medical generated −$10.4M of operating cash flow and spent $109K on capital projects, leaving free cash flow of −$10.5M. That is $4.0M less than in Q3 2025 (−$6.5M).

Over the twelve months to Sep 30, 2026, operating cash flow was −$42.4M; the largest uses were operating cash flow ($42.4M), capital spending ($508K); besides operations, cash came from other investing ($40.8M), other financing ($357K); the cash balance fell by $1.7M.

Operating cash flow was −$10.4M against net income of −$14.7M. The largest differences: inventory +$2.2M, receivables −$2.1M, stock-based pay +$1.7M.

Its cash conversion cycle was 275 days (receivables 82 + inventory 213 − payables 20).

Outset Medical is burning cash: its operations consume cash, a free cash flow of −$42.9M a year at the current rate against $137M of cash and investments: a runway of about 3.2 years before any new financing.